AbbVie's Humira regains top pharma TV spender spot, while sibling brands Rinvoq and Skyrizi tag along

AbbVie's Humira drop didn’t last long. While the blockbuster immunology med dropped out of the No. 1 pharma TV spending spot in March, it bounced right back in April.

AbbVie spent almost $23 million on national media buys for Humira, according to real-time TV ad tracker iSpot.tv, which landed it squarely atop the list again—just as it has quite reliably over the past five years.